Chemours (CC) PT Lowered to $18 at Morgan Stanley
Tweet
Share
E-mailGet Alerts CC Hot Sheet
Price: $14.88 -0.67%
Rating Summary:
9 Buy, 9 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 31
Rating Summary:
9 Buy, 9 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 31
Join SI Premium – FREE
Morgan Stanley analyst Vincent Andrews lowered the price target on Chemours (NYSE: CC) to $18.00 (from $21.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Constellation Brands (STZ) PT Lowered to $145 at UBS on Softer Consumer Backdrop
- Evolution Mining Ltd. (EVN:AU) (CAHPF) PT Lowered to AUD12.50 at RBC Capital
- Citi Upgrades Osotspa (OSP:TB) (OSOPF) to Buy
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
